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Abstract:  
Mitochondria vary in morphology and function in different tissues, however little is 
known about their molecular diversity among cell types. To investigate mitochondrial diversity 
in vivo, we developed an efficient protocol to isolate cell type-specific mitochondria based on 
a new MitoTag mouse. We profiled the mitochondrial proteome of three major neural cell types 
in cerebellum and identified a substantial number of differential mitochondrial markers for 
these cell types in mice and humans. Based on predictions from these proteomes, we 
demonstrate that astrocytic mitochondria metabolize long-chain fatty acids more efficiently 
than neurons. Moreover, we identified Rmdn3 as a major determinant of ER-mitochondria 
proximity in Purkinje cells. Our novel approach enables exploring mitochondrial diversity on 
the functional and molecular level in many in vivo contexts.  
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Mitochondria perform different tasks in diverse cell types. For instance, mitochondria 
control differentiation of immune and stem cells (1, 2). Similarly, in the nervous system, 
mitochondria regulate neurite branching (3, 4) and regeneration (5-7), as well as synaptic 
strength, stability and signaling (8, 9). While some of these cell type-specific functions are 
achieved by modulating the well-characterized metabolic roles of mitochondria, also entirely 
new functions emerge, e.g. in immune or redox signaling (10-12), and likely many more remain 
elusive.  
Bulk mitochondrial proteomes vary between tissues (13). Nevertheless, it remains unclear 
to what degree such diversity reflects tissue-specific global differences or variations in cellular 
composition. Moreover, genes encoding mitochondrial proteins are differentially expressed 
among tissues, cell types and even cell compartments (14-16) – but to what degree such 
transcriptional diversity results in mitochondrial proteome variability is not resolved. Indeed, 
while the extrapolation of proteomic data from transcriptomics is generally problematic         
(17, 18), the mitochondrial proteome is uniquely complex, especially in cells of extended 
geometry, such as neurons (19). Hence, in these complex cell types it is crucial to directly 15 
measure proteomic variability. Moreover, to test any resulting predictions it is important to 
obtain functional mitochondria from the respective cell of interest.  
Here, we describe such a novel approach that allows isolating functional mitochondria from 
essentially any cell type. This approach is based on a MitoTag mouse, which faithfully 
expresses an outer mitochondrial membrane (OMM)-targeted green fluorescent protein (GFP) 
in a Cre recombinase (Cre)-dependent manner. This innocuous and efficient epitope allows 
capturing cell type-specific mitochondria. We highlight the power of our approach by 
comparing neural mitochondria of the three major cell populations from cerebellum. Thus, we 
(i) provide a first systematic profiling of the cell type-specific variability between 
mitochondrial proteomes in situ; (ii) identify numerous cell type-specific mitochondrial 
markers in mouse and human brain; (iii) predict and prove metabolic differences in beta-
oxidation between neural cells; and (iv) characterize Rmdn3, a cell type-specific mediator of 
mitochondrial organelle contact sites in cerebellum. 
RESULTS 
MitoTag mice allow innocuously tagging of cell type-specific mitochondria in vivo 30 
Previous work established tagging of macromolecular structures like ribosomes to explore 
cell type-specific mRNA translation profiles in situ (20, 21). This approach has been recently 
extended to organelles, e.g. to explore mitochondrial (22) and lysosomal (23) metabolomes in 
vitro, organellar DNA in invertebrates (24) or to correlate transcriptional and epigenetic 
signatures (25). To study mitochondrial diversity among cell types in situ, i.e. directly derived 
from their tissue context, we generated a novel reporter line, named MitoTag mouse (Fig. 1A). 
MitoTag mice harbor in their Rosa26 locus a floxed “stop” expression cassette, which drives 
expression of GFP targeted to the outer mitochondrial membrane (OMM) in a Cre-dependent 
manner (GFP-OMM) (26). To achieve GFP-OMM expression in diverse cell types of the 
central nervous system, MitoTag mice were crossed to different Cre-driver lines (Fig. S1). 
Initial characterization was performed on (i) Emx1:Cre crossed to MitoTag mice (abbreviated 
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as ‘Emx1:Cre/GFP-OMM’), where the great majority of forebrain neurons and glia contained 
GFP-OMM-tagged mitochondria (Fig. 1B, S1A) (27); and (ii) on ChAT:Cre/GFP-OMM mice, 
where mitochondria in cholinergic neurons, including motor neurons, are tagged (Fig. S1B). 
First, we confirmed mitochondrial localization of GFP-OMM by counterstaining 45 
Emx1:Cre/GFP-OMM cortex with the endogenous inner mitochondrial membrane protein 
Cox4 isoform 1 (Cox4i1; Fig. 1C). We corroborated OMM localization by expansion 
microscopy (28) in Emx1:Cre/GFP-OMMxThy1:mito-RFP mice (Fig. 1D), which additionally 
express matrix-localized red fluorescent protein (mito-RFP) in neurons. Second, we used 
ChAT:Cre/GFP-OMM mice to rule out adverse transgene effects on mitochondrial and cellular 
health in motor neurons by measuring mitochondrial transport and shape, as well as 
neuromuscular synapse morphology (Fig. S2A-D). Finally, crude mitochondrial fractions 
(CMF) from Emx1:Cre/GFP-OMM cortex showed unchanged oxygen consumption rates 
compared to controls (Fig. S2E).  
To isolate GFP-OMM-tagged mitochondria, we optimized an immunocapture protocol 
using anti-GFP magnetic microbeads (IC GFP; Fig. 1E). This method is well established for 
mitochondria based on anti-Tom22 microbeads (29, 30), but has recently been expanded to 
neoantigens (22, 24). Indeed, for Emx1:Cre/GFP-OMM cortex, Western blot analysis 
corroborated efficient mitochondrial enrichment via IC GFP (Fig. S3A). Using electron 
microscopy, the majority of GFP-captured objects were isolated mitochondria with well-60 
preserved ultrastructure in contrast to the CMF, which contained synaptosome-enclosed 
mitochondria and myelin debris (Fig. 1F). Moreover, mitochondria that were immunocaptured 
from either control cortex (Cre- MitoTag mice; using anti-Tom22 microbeads, IC Tom) or 
Emx1:Cre/GFP-OMM cortex (~75% GFP-OMM-tagged mitochondria; Fig. S4B), did not 
differ in respiratory capacity (Fig. 1G).  
MitoTag mice allow isolation of cell type-specific mitochondria from complex tissues in 
situ  
A major concern in enriching cell type-specific mitochondria from tissue is that during the 
isolation, mitochondria from different cells could merge by clumping or fusion (31). Indeed, 
we observed that once we pelleted mitochondria by centrifugation, separation via IC GFP was 
impaired. Therefore, to determine the selectivity of our immunocapture, we devised “spike-in” 
experiments with mitochondria carrying mito-RFP. First, we used an ex vivo mixing 
experiment where cortex from Emx1:Cre/GFP-OMM mice and from Thy1:mito-RFP mice 
were mixed one-to-one (50:50%) and subjected to immunocapture (Fig. 2Ai). Using Western 
blot analysis, we observed that IC Tom recovered the initial GFP-OMM/mito-RFP ratio of the 75 
CMF, while tagged mitochondria were selectively enriched with IC GFP (GFP-OMM: 4.7-fold 
compared to IC Tom; Fig. 2B and C). We mimicked cell populations with various abundance 
by mixing the post-nuclear fractions from Emx1:Cre/GFP-OMM and Thy1:mito-RFP cortex 
in different ratios and found that the isolation efficacy stayed stable down to dilutions of 1:20 
(Fig. S5A and B). Throughout, we detected 5% of mito-RFP in IC GFP. To corroborate this 
experiment in vivo, we used ChAT:Cre/GFP-OMM cortex, where less than 1% of 
mitochondria are tagged (Fig. S4B) – representing a low abundant population of exclusively 
axonal mitochondria from cholinergic neurons. Still, the immunocapture allowed us to enrich 
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substantial amounts of mitochondria (Fig. S5C). Finally, to corroborate enrichment of tagged 
mitochondria from tissue, we immunocaptured astrocytic mitochondria from Gfap:Cre/GFP-
OMMxThy1:mito-RFP cortex (Fig. 2Aii). This tissue contained ~20% GFP-OMM-labeled 
mitochondria from astrocytes and 63% mito-RFP-positive neuronal mitochondria (Fig. S4B). 
Here, from immediately adjacent cells, GFP-OMM could be enriched to 7.4-fold compared to 
IC Tom (Fig. 2D).  
Mitochondrial diversity profiled by label-free proteomics in the adult cerebellum 90 
The cerebellum is composed of various well-characterized cell types, for which specific 
Cre-driver lines are available, and is prone to mitochondrial dysfunction (32, 33). Thus, we 
used the cerebellum as a proof-of-concept to test whether our MitoTag approach could resolve 
cellular diversity of the mitochondrial proteome in situ. First, we generated MitoTag lines for 
the following cell types (Fig. 3A, S1C-E): (i) Purkinje cells via L7:Cre, the major inhibitory 
neuron of the cerebellum; (ii) granule cells via Gabra6:Cre, the most abundant excitatory 
neuron; and (iii) astrocytes via Gfap:Cre. Next, we developed a label-free proteomic workflow 
for the comparison of mitochondrial proteomes that involved immunocapture of cell type-
specific mitochondria (IC GFP) and total tissue mitochondria (IC Tom) per biological replicate 
(N5 mice; Fig. S6 and Data Table S1). IC Tom provided an ‘average mitochondrial 
proteome’ from cerebellum – thereby correcting for variation among experiments and mouse 
cohorts. In this background proteome, we quantified 3,718 proteins, which we compared to 
reference proteomic data sets from mouse cerebellar mitochondria (13) and from whole 
cerebellum (34) revealing a coverage of 68% MitoCarta (35) annotated proteins (Fig. S3B). 
Moreover, intensity-based absolute quantification (iBAQ) demonstrated strong enrichment of 105 
mitochondrial proteins over non-mitochondrial proteins (e.g. 6.2-fold for IC TOM from 
L7:Cre/GFP-OMM) – despite our deliberate choice of a ‘conservative’ isolation approach with 
the aim to include transiently OMM-associated proteins for discovery and preserve organelle 
functionality (36). In comparison, a recent whole brain proteome study without mitochondrial 
enrichment revealed that mitochondrial proteins were 1.6-fold more abundant than non-
mitochondrial proteins (34). In contrast, Percoll-purified mitochondria from cerebellum 
showed a 6.2-fold increased abundance of mitochondrial over non-mitochondrial proteins in 
the MitoCarta proteomic dataset (13) matching our own enrichment. Indeed, 56.5% of peptides 
accounted for mitochondrial proteins in immunocaptures (Fig. S3C). Importantly, 
mitochondrial proteins showed more prominent abundance changes than non-mitochondrial 
proteins. For Purkinje cells, 23.1% of mitochondrial annotated proteins showed a significant 
abundance change (IC GFP/IC Tom ratio >1.5 or <0.67, and p<0.05), while only 4.0% of the 
non-mitochondrial annotated proteins were significantly changed – suggesting that most of the 
latter are not specifically captured. We further compared our Purkinje cell-specific dataset (IC 
GFP of L7:Cre/GFP-OMM; Fig. S3D) to the first in vivo whole-cell proteome from Purkinje 120 
cells obtained by metabolic labeling of nascent proteins (37). This revealed the superior 
sensitivity of our approach in detecting mitochondrial proteins (MitoCarta coverage: 69% vs. 
15%).  
In total, over 85% of identified proteins were shared among all three cell types (Fig. S6). 
We identified 196 candidates with differential expression (log2 fold change ≥│1│ between cell 
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types), of which 89.8% are mitochondrial annotated. Of these, 18, 51 and 114 were exclusively 
enriched in one cell type (Fig. 3B, S7D). An additional 13 proteins showed shared enrichment 
in two cell types. When we compared proteins from astrocytic mitochondria against either 
mitochondria from granule cell (y-axis; Fig. 3C, S7A and D) or Purkinje cell (x-axis; Fig. 3C, 
S7B and D), we detected a separation in protein composition of neuronal mitochondria from 
glial mitochondria. Equally, KEGG pathway (Fig. S7E) and GOTerm process analysis (Fig. 
S7F) confirmed differential specializations of neuronal (e.g. ubiquinone biosynthesis) vs. 
astrocytic mitochondria (e.g. lipid metabolism). In contrast, other mitochondrial protein 
pathways (e.g. respiratory chain components, protein import and translation, TCA cycle) 
showed no systematic differences, pointing to a conserved core of the mitochondrial proteome 135 
(Fig. S8).  
We selected 30 candidates for further validation based on literature and antibody 
availability: Cox4i1 as a ubiquitous mitochondrial marker, syntaphilin (Snph) as a neuronal 
mitochondrial marker not significantly enriched in the tested cell types and 28 as cell type-
enriched proteins.  Using immunofluorescence stainings (Fig. 3D-F, S9), we confirmed in all 
testable cases (23/30) the predicted cell type-specific enrichment and subcellular localization 
in mitochondria. In seven cases, no confirmation could be achieved due to antibody quality. 
Some of the validated candidates – especially in astrocytes (Fig. 3F) – represent mitochondrial 
proteins with previously cell type-specific annotation, such as glycine dehydrogenase (Gldc) 
(38), sideroflexin-5 (Sfxn5) (39) and monoamine-decarboxylase B (MaoB), which is targeted 
in positron emission tomography as astrocyte tracer (40). Notably, the astrocytic mitochondrial 
proteome also contained a substantial enrichment of peroxisomal proteins                                     
(Fig. S7E and F, S9), some of which are known to have dual targeting (e.g. catalase) (41, 42) 
or tether to mitochondria (e.g. Eci2 and Pex11b) (43, 44). In neurons, we expected to identify 
Snph, a protein involved in regulating mitochondrial distribution and generally believed to be 150 
enriched on axonal mitochondria (45). Indeed, in line with our proteomics we confirmed only 
weak signals in Purkinje cell and granule cell mitochondria; however, we additionally observed 
prominent mitochondrial labeling in Basket axon collaterals synapsing onto Purkinje cell 
somata – hence forming the pinceau organization (Fig. 3D, S9B). In some instances, e.g. for 
mitochondrial adenylate kinase or glutaminase, differential paralogs were detected between 
cell types (Ak4 vs. Ak3; Gls vs. Gls2; Fig. 3E and F). In addition, we observed two forms for 
Ociad2, a non-MitoCarta protein dually assigned to mitochondria and endosomes in a recent 
publication (46). A C-terminal antibody confirmed our proteomic prediction of enrichment in 
Purkinje cell mitochondria, while an N-terminal antibody showed enrichment in granule cells 
(Fig. S10). Surprisingly, we identified cell type-specific enrichment of mitochondrial proteins 
for which we expected ubiquitous expression – e.g. the mitochondrial calcium uniporter (Mcu; 
Fig. 3E) and its regulators (47-49)  in granule cells. Similarly, Regulator of microtubule 
dynamics protein 3 (Rmdn3, also known as PTPIP51), a tether involved in calcium handling 
(50) and lipid transfer (51) between the endoplasmic reticulum (ER) and mitochondria, was 
enriched in Purkinje cells.  165 
Altogether, our validated group of cell type-specific proteins supports the notion that 
depending on cell type, mitochondria play diverse roles, e.g. in metabolism, calcium handling 
and organelle communication. Importantly, when we tested a subset of our mitochondrial 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
   7 
markers on human cerebellar tissue, we found the expression patterns to be preserved (Fig. 4) 
– opening up the possibility to explore cell type-specific mitochondrial pathology in humans. 
Thus, our results point to a so far unappreciated profound organellar diversity among cell types 
in vivo. 
Fatty acids are more efficiently metabolized by astrocytic than neuronal mitochondria 
 Pathway analysis between neuronal and astrocytic mitochondria revealed an enrichment of 
enzymes involved in mitochondrial beta-oxidation (Fig. 5A, S7E). However, the brain is often 
assumed to rely on glucose and lactate for energy production, rather than lipids (52, 53). Still, 
neural cells appear to respire on fatty acids under certain conditions (54, 55) with important 
functional implications, e.g. stem cell proliferation (56, 57). Despite this, whether long-chain 
fatty acids support respiration in neural cells under steady-state conditions remains 
controversial. Guided by our proteomic profiling, we addressed this question by first 180 
confirming the astrocytic enrichment of two enzymes involved in beta-oxidation by 
immunofluorescence staining, short-chain specific acyl-CoA dehydrogenase                        
(Acads; Fig. 3F, S9C) and carnitine palmitoyltransferase 1a (Cpt1a; Fig. 5B), a rate limiting 
enzyme in long-chain fatty acids oxidation (58). Secondly, we used our approach to compare 
oxygen consumption rates of in situ isolated cell type-specific mitochondria on the C16-fatty 
acid, palmitoyl-carnitine (Fig. 5C, S11). We chose a substrate that is preferentially metabolized 
in mitochondria due to its carbon chain length and carnitine pre-conjugation (59, 60), because 
astrocytic mitochondria appear to engage selectively with peroxisomes based on our proteomic 
profiling (Fig. S7E and F). Astrocytic mitochondria performed significantly better than 
Purkinje cell-derived mitochondria in coupling efficiency (astrocytic vs. Purkinje cell 
mitochondria; CE:1.2-fold; p=0.03, one-tailed Welch´s t-test; N≥9), respiratory capacity ratio 
(RCR: 1.6-fold; p<0.001) and spare capacity ratio (SCR: 1.7-fold; p<0.001). In contrast, 
selective respiration via complex I and II did not differ significantly (Fig. 5D and E, S11).  
Rmdn3 mediates ER-mitochondria juxtapositions in Purkinje cells 
A central aspect of mitochondrial function is communication with other organelles, e.g. 195 
via contact sites (61-63). Rmdn3 is an established tether between the ER and mitochondria 
involved in calcium and lipid transfer (50). In our proteomic profiling, we found this OMM 
protein (64) to be enriched 3.5-fold over granule cell mitochondria and 4.1-fold over astrocytic 
mitochondria. Previous reports established the interaction of Rmdn3 with ER-membrane 
proteins, namely VAPB (an amyotrophic lateral sclerosis-associated protein) (50) and ORP5/8 
(51). First, we confirmed by immunofluorescence staining that Rmdn3 is highly enriched in 
Purkinje cell mitochondria (Fig. 6A) (65). Next, we tested the resulting prediction of more 
extensive mitochondria-ER contacts in Purkinje cells compared to astrocytes by ultrastructural 
analysis. Indeed, ER-mitochondria contacts were 2.7-fold more extensive in Purkinje cell 
somata compared to neighboring astrocytes (≤30 nm distance: 38% Purkinje cells vs. 14% 
astrocytes; two-tailed unpaired t-test, p<0.0001, N≥10 cells from two mice; Fig. 6B, S13A). 
Finally, we confirm that these juxtapositions are affected by Rmdn3 levels using a new 
knockout mouse model. These mice showed a gene dose-dependent protein loss in cerebellum 
by Western blot and immunofluorescence analysis (Fig. 6C and D), even though some non-
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specific bands and residual non-neuronal staining persisted. Ultrastructural appraisal 210 
demonstrated a reduction of ER-mitochondria contacts in Purkinje cell somata (+/+, 37%; +/-, 
28%; -/-, 20%; one-way ANOVA with Tukey’s post-hoc test, +/+ vs. -/-: p<0.0001 and +/+ vs. 
+/-: p=0.0022, +/- vs. -/-: p=0.0016, N≥8 cells from 2-3 mice; Fig. 6E, S13B), while contacts 
in astrocytes were not significantly altered.  
DISCUSSION  
Here, we describe a versatile approach to obtain intact cell type-specific mitochondria 
from complex tissues. This approach allows for functional and ‘omics’-level analysis of 
mitochondria derived from any cell type during development, physiology and disease. We 
demonstrate this by comparing the mitochondrial proteomes of the principal inhibitory and 
excitatory neurons, as well as of the major glial cell type in the mouse cerebellum. 
Compared to other methods that explore the molecular composition of mitochondria, our 
approach has a number of distinct advantages: (i) Mice of all ages and genotypes can be used, 
enabling studies of aging-related changes or disease models, which for many cell types are not 
possible with cell culture- or tissue dissociation-based approaches. (ii) In cells with extended 
morphology, mitochondria from all compartments can be obtained. We illustrate this by 225 
capturing axonal mitochondria from cholinergic forebrain projections (Fig. S4B, S5C).           
(iii) While transcriptomes provide insights into the regulation of mitochondrial gene 
expression, mitochondrial proteomes are shaped by multiple layers of regulation (19, 66, 67) 
and hence are even less predictable from transcriptomes than global cellular proteomes           
(17, 18) – a limitation that our direct proteomic approach circumnavigates. (iv) Our approach 
can yield proteins that are uncharacterized or only transiently associated with mitochondria that 
would be otherwise overlooked by methods relying on prior knowledge of mitochondrial 
localization. (v) In contrast to methods that are based on the affinity-purification of labeled 
proteins from cell types, e.g. via BONCAT (37) or APEX (68), our approach provides the intact 
and functional organelle for correlated analysis of the mitochondrial genome or transcriptome 
(14, 24) as well as of mitochondrial functions, e.g. respiration, calcium handling or ROS 
production. This is further aided by the fluorescent tag, which allows in situ observation, and 
the bulk IP approach, which is relatively swift and gentle – an important feature for functional 
and metabolic investigations (22). 
Indeed, when applied to the adult cerebellum, our approach yielded a number of novel 240 
insights: (i) It revealed profound mitochondrial diversity among cell types, with a significant 
part of the annotated mitochondrial proteome (15%) being differentially regulated among the 
cell types we investigated. (ii) Our verified cell type-specific mitochondrial proteins provide a 
set of in situ markers to characterize the number, distribution and morphology of mitochondria 
in specific cerebellar cell types without genetic labels across developmental stages and disease 
models. Several of these new mitochondrial markers are conserved in human tissue (Fig. 4), 
thus opening the path towards characterizing cell type-resolved mitochondrial changes in 
human disease. So far, this has only been possible for cellular compartments that are large 
enough to be resolved by light microscopy (69) or by using electron microscopy, which is 
cumbersome and highly susceptible to post mortem changes. (iii) Pathway analysis of our 
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cerebellar proteomes resulted in clear predictions for differentially regulated metabolic 
pathways (Fig. S7E), which we could directly confirm by demonstrating efficient beta-
oxidation in immunocaptured astrocytic mitochondria (Fig. 5C, S11). (iv) Chiming with this 
result, we observed an enrichment of peroxisomal proteins in captured mitochondria from 
astrocytes (Fig. S7E and F). As peroxisomes are another important compartment for lipid 255 
metabolism (70) and engage intimately with mitochondria, this interaction might enhance glial 
use of lipids and the exchange of proteins between mitochondria and peroxisomes, e.g. as part 
of peroxisome biogenesis (71). (v) Our proteomic profiling predicted candidates that mediate 
cell type-specific regulation of organelle contacts. For instance, we found a recently identified 
mitochondria-peroxisome tether, Pex11B (44), enriched in astrocytic mitochondria. Similarly, 
we identified Rmdn3 enriched in Purkinje cell mitochondria, which mediates ER-mitochondria 
contact sides (Fig. 6). (vi) The enrichment of Rmdn3 fits well with independent observations 
indicating unique intracellular calcium handling mechanisms in Purkinje cells relating to the 
distinct morphology, firing pattern and synaptic plasticity of this neuron (72). In contrast, 
mitochondrial calcium handling in granule cells seems to be governed by strong expression of 
the Mcu complex (Fig. 3E). A similar regulation of mitochondrial calcium handling has been 
observed in other excitable tissues (48, 73-75) either by tissue-specific expression of Mcu 
components (Micu1-3) or by posttranslational modification (e.g. redox state) (76). The low 
expression of the Mcu complex in Purkinje cells thus matches the close ER-mitochondria 
proximity mediated by Rmdn3, but could also relate to the high levels of cytoplasmic calcium 270 
buffers in Purkinje cells (e.g. parvalbumin), which in other cells downregulate Mcu expression 
(77). Overall this hints at hitherto unappreciated cell type-specific regulation of even basic 
mitochondrial functions in the central nervous system (78). 
Our data reveal that underneath the initial perception of mitochondria as rather uniform and 
autonomous organelles lies a layer of profound cell type-specific mitochondrial biology that 
we are only starting to appreciate. Given the startling tissue- and cell type-specificity of many 
pathologies involving mitochondria (2, 79) and the increasing number of roles ascribed to 
mitochondria as signaling hub, the MitoTag approach provides a valuable tool to recognize 
mitochondria fully as the multifaceted organelles that they are. 
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Main figure legends and figures: 
Figure 1. 
MitoTag mice allow isolation of intact and functional mitochondria from cells in situ:              
(A) Schematic of GFP-OMM insertion into the mouse Rosa26 locus (e1/2, exon 1&2; P, 
promoter). (B) Confocal micrographs of cerebral cortex shows no expression in stopped 
MitoTag tissue (left and middle panels; Cre -), but GFP-OMM (green) in neural cells from 
Emx1:Cre/GFP-OMM mice (right panel; Cre +). Nuclear counterstain, Nuc (left panel; 
Hoechst, white) shown for layer orientation. (C) Confocal imaging of Emx1:Cre/GFP-OMM 
cerebral cortex immunostained for cytochrome c oxidase subunit 4 isoform 1 (pan-
mitochondrial marker, Cox4i1; magenta) confirms mitochondrial localization of GFP-OMM 
(arrowhead). (D) Expansion microscopy of Emx1:Cre/GFP-OMMxThy1:mito-RFP cerebral 
cortex shows localization of GFP-OMM in the outer mitochondrial membrane (green) 
surrounding mito-RFP (magenta), which is expressed in the mitochondrial matrix of a large 
subset of neurons. (E) Schematic of the immunocapture (IC) protocol of GFP-OMM tagged 
mitochondria (CMF, crude mitochondrial fraction). (F) Electron micrographs comparing the 
CMF from Emx1:Cre/GFP-OMM cortex to IC GFP. Note free mitochondria (*) and 
synaptosome-enclosed mitochondria (#) found in CMF (upper panel) and free, intact 
mitochondria (x, +) with microbeads (black dots in micrograph, lower panel). (G) Bioenergetic 
parameters derived from oxygen consumption measurements in the presence of 
pyruvate/malate (left) and succinate/rotenone (right) as substrates for immunocaptured 
mitochondria. Mitochondria were immunocaptured from Emx1:Cre -/GFP-OMM or  
Emx1:Cre +/GFP-OMM cortex using Tom22 (pan-mitochondrial, IC Tom) or GFP-OMM (cell 
type-specific mitochondria, IC GFP) as bait (CE, coupling efficiency; RCR, respiratory 
capacity ratio; SCR, spare capacity ratio; N=4-7; no significant differences observed with one-
way ANOVA with multiple comparisons). Scale bars: 100 µm in B; 5 µm in C, D and inset 
(note that for D, an estimated expansion factor of ~2-3 applies); 500 nm in F (250 nm in inset). 
Figure 2.  
Immunocapture from MitoTag mice enriches cell type-specific mitochondria without 
mitochondrial cross-contamination from other cells: (A) Schematic of “spike-in” 
experiments to demonstrate enrichment of GFP-OMM tagged mitochondria from other 
mitochondria (mito-RFP). Using cortex, two mitochondrial populations (GFP-OMM,           
mito-RFP) were mixed either ex vivo on the tissue level (i) or in vivo (ii) by breeding        
Gfap:Cre/GFP-OMMxThy1:mito-RFP mice. (B, C) Enrichment of GFP-OMM-labeled 
mitochondria after immunocapture via GFP-OMM (IC GFP), but not via Tom22 (IC Tom) 
from ex vivo mixing experiment (schematic in Ai). Cortex from Emx1:Cre/GFP-OMM            
(C, top micrograph for tissue expression; GFP-OMM, green; Nuc, white) and cortex from 
Thy1:mito-RFP (C, bottom micrograph; mito-RFP, red; Nuc, white) were mixed in a 50:50% 
ratio before lysate generation (B; Mix, orange). (B) Western blot analysis of 10 µg protein per 
condition probed for GFP-OMM, mito-RFP and mitochondrial proteins (OMM, outer 
mitochondrial membrane – Tomm20; IMM, inner mitochondrial membrane – ATP5a; matrix 
– CypD). Note enrichment of GFP-OMM via IC GFP from pure Emx1:Cre/GFP-OMM tissue 
(Lysate: GFP-OMM) and the absence of any mitochondrial isolation from pure mito-RFP 
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tissue (Lysate: mito-RFP). (C) Quantification of ex vivo mixing experiment (schematic in Ai) 
comparing isolations to the crude mitochondrial fraction (CMF). Densitometry (GFP-OMM, 
green bar: p=0.0002; mito-RFP, red bar: p=0.037; N=5, one-tailed ratio-paired t-test) is 
normalized to mitochondrial content. (D) In vivo “spike-in” experiment (schematic in Aii) 
using cortex from Gfap:Cre/GFP-OMMxThy1:mito-RFP mice (micrograph for tissue 
expression; GFP-OMM, green; mito-RFP, red; Nuc, white) as starting material with a ~24:76% 
ratio (cf. Figure S4B). Bar graph shows quantification from Western blot analysis comparing 
IC Tom and IC GFP to initial CMF (GFP-OMM, p=0.0002; N=5, one-tailed ratio-paired t-test). 
Scale bars: 20 µm in C and D. 
Figure 3. 
Proteomic profiling of cell type-specific mitochondria in the adult mouse cerebellum:             
(A) Confocal micrographs illustrate GFP-OMM expression patterns (green) and Cox4i1 
staining (pan-mitochondrial; magenta) in the investigated cerebellar cell types: astrocytes (left 
panel, Gfap:Cre; note that molecular layer astrocytes are also known as Bergmann glia), 
excitatory granule cells (middle panel, Gabra6:Cre) and inhibitory Purkinje cells (right panel, 
L7:Cre). Each schematic shows cell morphology and anatomical position within the cerebellum 
(ML, molecular layer; PCL, Purkinje cell layer; GCL, granule cell layer). Details show partial 
co-localization of cell type-specific GFP-OMM with Cox4i1. (B) Venn diagram depicting 
candidates (N=196) with cell type-specific enrichment obtained by proteomics (fold change 
≥│1│ from the pairwise comparison between cell types; PC: Purkinje cells; A: astrocytes; GC: 
granule cells) and their subcellular localization (Mito, mitochondria; Cyto, cytosol; Nuc, 
nuclus; ER, endoplasmic reticulum; Pex, peroxisome; PM, plasma membrane; other).               
(C) Comparison of cell type-specific mitochondrial proteomes between cell types (upper part: 
volcano plots comparing GC/A, left; and PC/A, right; two-tailed t-test, FDR≤0.05, 500 
randomizations, N≥3; dark gray, proteins passing FDR) and among cell types (lower part: 
scatter plot of proteins merging the previous comparison between cell types (FDR≤0.05 in at 
least one comparison); x-axis, PC/A; y-axis, GC/A). In volcano plots: dark gray circles, 
proteins FDR≤0.05. In scatter plot: all circles, proteins from volcano plots with FDR≤0.05; 
black circles, MitoCarta annotated proteins; open magenta circles, candidates illustrated in A, 
D-F. (D-F) Validation of candidates by immunofluorescence staining in cerebellum. 
Candidates (magenta) show prominent co-localization with cell type-specific GFP-OMM 
(green) confirming the proteomic data (see C) in Purkinje cells (D), granule cells (E) and 
astrocytes (F). Note the pan-neuronal patterns of Ldhd, Gls2 and Got2 (D and E) and the 
pinceau-like organization of Snph likely in Basket axon collaterals around Purkinje cell soma. 
GFP-OMM is driven by the Cre-driver lines introduced in A. Arrowhead, nuclear signal. Scale 
bar: 20 µm in A, and D-F (10 µm in details).
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Figure 4. 
Cell type-specific mitochondrial markers are conserved in human cerebellum:                            
(A, B) Overview with details of immunostainings for Rmnd3 (A, magenta) and Cpt1a                
(B, magenta) in post mortem human cerebellum. (A) Rmdn3 marks Purkinje cell mitochondria 
(PC; cell type marker: calbindin, green). (B) Cpt1a identifies astrocytic mitochondria (A; cell 
type marker Gfap, green). Nuc, nuclear counterstain (DAPI; white). (C) Details of four cell 
type-specific mitochondrial markers illustrate the diverse shapes and quantities of 
mitochondria in human cerebellum. Mcu is enriched in granule cell (GC; first from left). Note 
intense signal in granule cell layer in comparison to Purkinje cell soma and molecular layer 
signals. Got2 is pan-neuronal (neuro; second from left) and Sfxn5 is astrocytic (A; second from 
right). Cox4i1 shows pan-mitochondrial labeling (pan, first from right). Note the broad signal 
with loss of individual mitochondrial shapes due to proximity. ML, molecular layer; PCL, 
Purkinje cell layer; GCL, granule cell layer. Scale bars: 50 µm in A and B upper panel; 20 µm 
in A and B lower panel (10 µm in details); 25 µm in C. 
Figure 5. 
Astrocytic mitochondria metabolize long-chain fatty acids more efficiently than neurons: 
(A) Schematic depicting the localization of the three steps of beta-oxidation in mitochondria:    
(1) Fatty acid (FA) import, (2) FA initial breakdown and (3) FA final breakdown. Heat map 
showing cell type-specific protein changes for enzymes involved in beta-oxidation as average 
log2 fold change of IC GFP/IC Tom (PC, Purkinje cell; GC, granule cell; A, astrocyte).                                   
(B) Immunostaining for carnitine palmitoyltransferase 1a (Cpt1a, magenta) co-localizes with 
astrocytic mitochondria in cerebellum (right panel; Gfap:Cre/GFP-OMM, green). Staining is 
additionally shown in tissue from Cre -, L7:Cre/GFP-OMM and Gabra6:Cre/GFP-OMM mice. 
Arrowhead, nuclear signal as previously reported for Cpt1a (80). (C-E) Bioenergetic 
parameters derived from oxygen consumption measurements of immunocaptured mitochondria 
from Purkinje cells (PC, L7:Cre/GFP-OMM) or astrocytes (A, Gfap:Cre/GFP-OMM), in the 
presence of different substrates (CE, coupling efficiency; RCR, respiratory capacity ratio; SCR, 
spare capacity ratio). (C) All parameters under palmitoyl-carnitine/malate are significantly 
higher in astrocytic mitochondria (CE: p=0.0436; RCR: p=0.0001; SRC: p<0.0001, N=9-10; 
unpaired t-test with Welch´s correction). (D) Parameters under pyruvate/malate and (E) 
succinate/rotenone do not show any significant difference. For comparison, parameters are 
normalized to corresponding IC Tom value (gray bar; cf. Figure S11 for non-normalized 
values). Scale bar: 25 µm in C (5 µm in detail). 
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Figure 6. 
Rmdn3 mediates close ER-mitochondria juxtapositions in Purkinje cells:                                 
(A) Immunostaining for Rmdn3 (magenta) co-localizes with Purkinje cell mitochondria in 
mouse cerebellum (second panel from left; L7:Cre/GFP-OMM, green). Staining is additionally 
shown in tissue from Cre-, Gfap:Cre/GFP-OMM and Gabra6:Cre/GFP-OMM mice.                   
(B) Ultrastructural analysis of ER-mitochondria proximity in wild type cerebellum reveals the 
degree of proximity of ER (orange) to mitochondria (magenta) in the cytoplasm of Purkinje 
cells (left panel) and adjoining astrocytes (right panel). Note differing scale bar sizes due to 
mitochondrial size. The contact frequency between organelles is shown as % mitochondrial 
perimeter in distance ≤30 nm (red lines in panels) and illustrated as bar graph using cells as 
statistical entities (p<0.0001, N= 10 vs. 16 cells from two animals; two-tailed unpaired t-test). 
Dot plot shows the population of mitochondria per genotype and cell type                                
(N≥120 mitochondria, magenta dots, from two mice). (C, D) Rmdn3 knockout mice show a 
gene dose-dependent reduction in Rmdn3 protein levels in the cerebellum. (C) 20 µg protein 
from cerebellum of wild type (+/+), heterozygous (+/-) and knockout (-/-) mice were analyzed 
via Western blot probing for Rmdn3 (size: 51 and >130 kDa) and mitochondrial proteins 
(ATP5a, CypD). Bar graph shows quantification of Rmdn3 levels relative to mitochondrial 
content (+/+ vs. -/-: p<0.0001, +/+ vs. +/-: p=0.0003, N=4; two-tailed paired t-test).                     
(D) Immunostaining for Rmdn3 (magenta) in wild type (left panel; +/+) and knockout (right 
panel; -/-) cerebellum shows loss of mitochondrial pattern in Purkinje cells. Weak residual 
signal in astrocytic mitochondria might be due to imperfect specificity of the antibody for the 
canonical form (52 kDa) of Rmdn3, cf. Figure S12B. Nuclei, nuc, white. (E) Ultrastructural 
analysis of ER-mitochondria proximity in Rmdn3 knockout cerebellum reveals reduced contact 
frequency (ER, orange; mitochondria, magenta; contact, red lines) in the cytoplasm of Purkinje 
cells (electron micrograph). Bar graph shows the decrease in contact frequency between 
organelles based on cells as statistical entities (≤30 nm distance; +/+ vs. -/-: p<0.0001, +/+ vs. 
+/-: p=0.0022, +/- vs. -/-: p=0.0016, N≥8 cells from 2-3 mice; one-way ANOVA with Tukey’s 
post-hoc test) in Purkinje cells but not in astrocytes (+/+ vs. -/-: p=0.17, +/+ vs. +/-: p=0.12, 
N≥10 cells from 2-3 mice). Dot plot shows the population of mitochondria per genotype and 
cell type (N≥105 mitochondria, magenta dots, from 2-3 mice). Scale bars: 25 µm in A (5 µm 
in detail); 200 nm in B, E; 20 µm in D. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
 Figure 1  18 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
 Figure 2  19 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
 Figure 3  20 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
 Figure 4  21 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
 Figure 5  22 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
 Figure 6  23 
 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/403774doi: bioRxiv preprint first posted online Aug. 29, 2018; 
